IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $6,741,000 | -58.1% | 5,185,383 | +11.3% | 0.88% | -37.6% |
| Q3 2018 | $16,071,000 | -15.1% | 4,658,353 | +12.0% | 1.41% | -23.6% |
| Q2 2018 | $18,921,000 | +39.6% | 4,158,353 | +1.3% | 1.85% | +34.4% |
| Q1 2018 | $13,550,000 | +136.4% | 4,106,200 | +179.4% | 1.37% | +98.8% |
| Q4 2017 | $5,732,000 | -31.7% | 1,469,800 | +19.1% | 0.69% | -51.6% |
| Q1 2017 | $8,391,000 | +15.6% | 1,233,976 | -6.5% | 1.43% | -2.2% |
| Q4 2016 | $7,261,000 | -20.2% | 1,320,164 | +10.0% | 1.46% | -14.9% |
| Q3 2016 | $9,096,000 | – | 1,200,000 | – | 1.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,208,210 | $16,738,232,000 | 18.66% |
| ProQuest Associates IV LLC | 1,962,720 | $14,877,000 | 4.10% |
| BVF INC/IL | 1,200,000 | $9,096,000 | 1.71% |
| Abingworth LLP | 197,300 | $1,494,000 | 1.43% |
| NEXTHERA CAPITAL LP | 305,000 | $2,312,000 | 1.42% |
| Cormorant Asset Management, LP | 432,990 | $3,282,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 203,000 | $1,539,000 | 0.25% |
| DAFNA Capital Management LLC | 40,000 | $303,000 | 0.21% |
| Monashee Investment Management LLC | 50,000 | $379,000 | 0.13% |
| Eventide Asset Management | 180,000 | $1,364,000 | 0.08% |